HEALTHEQUITY, INC. Research And Development Expense

Quick Answer

HEALTHEQUITY, INC. reported Research And Development Expense of $262.51 million for the year ending 2026.

  • HEALTHEQUITY, INC. showed an increase of +9.6% in Research And Development Expense from 2025 to 2026.
  • This data is from HEALTHEQUITY, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
  • XBRL data for this metric is available from 2013 to 2026 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2013: $1.66 million | Q4 2013: $1.80 million | Q2 2014: $2.19 million | Q3 2014: $2.30 million | Q4 2014: $2.81 million | Q2 2015: $3.52 million | Q3 2015: $4.00 million | Q4 2015: $4.42 million | Q2 2016: $4.63 million | Q3 2016: $4.99 million | Q4 2016: $6.21 million | Q2 2017: $6.24 million | Q3 2017: $6.80 million | Q4 2017: $6.87 million | Q2 2018: $7.98 million | Q3 2018: $8.40 million | Q4 2018: $8.68 million | Q2 2019: $10.91 million | Q3 2019: $11.65 million | Q4 2019: $23.51 million | Q2 2020: $31.08 million | Q3 2020: $30.65 million | Q4 2020: $30.76 million | Q2 2021: $35.47 million | Q3 2021: $37.90 million | Q4 2021: $38.07 million | Q2 2022: $45.18 million | Q3 2022: $46.58 million | Q4 2022: $48.89 million | Q2 2023: $53.19 million | Q3 2023: $54.77 million | Q4 2023: $55.61 million | Q2 2024: $56.09 million | Q3 2024: $58.58 million | Q4 2024: $60.19 million | Q2 2025: $61.44 million | Q3 2025: $64.80 million | Q4 2025: $65.92 million.
  • Over the full 14 years of available data (2013 to 2026), HEALTHEQUITY, INC.'s Research And Development Expense has grown by 6,107.4%.
  • Historical annual values: Fiscal year 2026: $262.51 million | Fiscal year 2025: $239.51 million | Fiscal year 2024: $218.81 million | Fiscal year 2023: $193.38 million | Fiscal year 2022: $157.36 million | Fiscal year 2021: $124.81 million | Fiscal year 2020: $77.58 million | Fiscal year 2019: $35.06 million | Fiscal year 2018: $27.39 million | Fiscal year 2017: $22.38 million | Fiscal year 2016: $16.83 million | Fiscal year 2015: $10.50 million | Fiscal year 2014: $7.14 million | Fiscal year 2013: $4.23 million.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: